Early Drivers of Autoimmune Kidney Damage Identified, Opening Door to Targeted Treatment
Oct 19, 2026
Researchers uncovered how injured kidney cells recruit immune cells that worsen inflammation and demonstrated an experimental antibody strategy that reduced kidney damage in mice.
Read MorePGDx elio® tissue complete CDx Brings Speed and Confidence to Advanced Melanoma BRAF Testing
Oct 19, 2026Breast Cancer Treatment Response Predictors Revealed Through Multi-Omics Analysis
Oct 16, 2026Cancer Genetic Testing Uptake Improves with Digital Outreach and Health Coaching
Oct 14, 2026Advanced Omics Reveal ‘Poor Outcome’ Marker for Neuroblastoma
Oct 14, 2026Mechanical Pressure Triggers Cancer Cell Death, Revealing Potential New Defense Against Metastasis
Oct 14, 2026Magnetic Millirobots Could Deliver Cancer Drugs Directly to Hard-to-Reach Tumors
Oct 14, 2026In Conversation with Magda Kordon-Kiszala
Oct 20, 2026
Karolinska’s Multi-Omics Moment: An Interview with Christophe Pedroletti
Oct 20, 2026
The Quest for Wellness: Five Companies Preventing Disease with Precision Diagnostics
Oct 19, 2026
African Ancestry Genetic Variant Increases Risk for Cardiomyopathy
Oct 19, 2026
Antibody Signatures Could Reveal IBD Risk 10 Years Before Diagnosis
Oct 18, 2026
GLP-1 Drugs Linked to Fewer Heart Complications and Infections After Surgery
Oct 18, 2026
News & Features
Gene-Edited CAR T Expands Rare Disease Horizons
August 01, 2026Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible
August 01, 2026Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon…
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments
August 01, 2026The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial…
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.
Surbhi Jain, PhD, MBBS
Staff Scientist
Bio-Rad Laboratories
Prithwish Pal, PhD
Director, Global Product Marketing – Oncology
Bio-Rad Laboratories
Key Molecular Driver Implicated in Osteoporosis
Oct 15, 2026Targeting a vital cellular signaling pathway that contributes to bone loss together with supplementation of a vitamin B derivative could help prevent osteoporosis.
Worlds Apart: Genomics Experts Still Split on Newborn Sequencing Guidelines
Oct 14, 2026The 2026 International Consortium on Newborn Sequencing (ICoNS) conference revealed major disagreements over when to test, what to disclose, and how to use genetic information…
Metabolomic Aging Clock Predicts Chronic Disease, Mortality Risk
Oct 14, 2026A study of 18,476 participants identified two metabolomic aging metrics that showed that people whose metabolomic age exceeded their chronological age had higher risks of…
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
